• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[支气管源性癌的外科治疗。496例手术患者的长期结果]

[Surgical treatment of bronchogenic carcinoma. Long-term results in 496 surgical patients].

作者信息

Fiala P, Kubík A

机构信息

Klinika pneumologie a hrudní chirurgie 3, LF UK, Praha.

出版信息

Cas Lek Cesk. 1998 Apr 6;137(7):211-5.

PMID:9650343
Abstract

BACKGROUND

The operability of lung cancer and the period of survival after resection of the lungs in our country does not yet attain the standard recorded in some advanced countries. The objective of the present work is to analyze factors which influence the survival period after resection therapy of lung cancer.

METHODS AND RESULTS

In 1985-90 in our department 496 patients were operated on account of lung cancer. This number comprised 31 patients subjected to explorative thoracototomy and three patients with pulmonary resection on account of a stage IIIb (pTNM) tumour who were excluded from the statistical analysis. The retrospective study proper analyzes the results of 462 patients (403 men and 59 women) operated in stages I, II and IIIa. Their mean age was 57 years (range 30-74 years, SD 7.5 years). The most frequent histological type was epidermoid carcinoma (68.8%), adenocarcinoma 18.2%, small-cell tumours 5.4% (25 patients). In 262 patients operated on account of lung cancer in stage I (pTNM) the probability of five-year survival was 49.2%, in patients in stage II 42.1%, in 158 patients in stage IIIa 20.9% (for all histological types combined). In 437 patients after resection of the lungs on account of non-small-cellular carcinoma the probability of five-year survival was as follows: stage I 50.0%, stage II 45.0%, stage IIIa 21.2%.

CONCLUSIONS

The probability of five-year survival for the whole group of 462 patients in stages I, II and IIIa was 38.8%. The most important factor which influenced the probability of five-year survival was the stage of the disease. Neither age nor sex of the patients nor the histological type of the tumour had a statistically significant effect on the probability of five-year survival.

摘要

背景

我国肺癌的可切除性以及肺切除术后的生存期尚未达到一些发达国家所记录的标准。本研究的目的是分析影响肺癌切除治疗后生存期的因素。

方法与结果

1985 - 1990年,我科对496例肺癌患者进行了手术。其中包括31例行 exploratory thoracototomy(探查性开胸术)的患者以及3例因Ⅲb期(pTNM)肿瘤行肺切除术的患者,这3例患者被排除在统计分析之外。本回顾性研究实际分析了462例(403例男性和59例女性)接受Ⅰ、Ⅱ和Ⅲa期手术的患者结果。他们的平均年龄为57岁(范围30 - 74岁,标准差7.5岁)。最常见的组织学类型是鳞状细胞癌(68.8%),腺癌18.2%,小细胞肿瘤5.4%(25例患者)。在262例因Ⅰ期(pTNM)肺癌接受手术的患者中,五年生存率为49.2%,Ⅱ期患者为42.1%,158例Ⅲa期患者为20.9%(所有组织学类型合并计算)。在437例因非小细胞癌行肺切除术后的患者中,五年生存率如下:Ⅰ期50.0%,Ⅱ期45.0%,Ⅲa期21.2%。

结论

462例Ⅰ、Ⅱ和Ⅲa期患者的五年生存率为38.8%。影响五年生存率的最重要因素是疾病分期。患者的年龄、性别以及肿瘤的组织学类型对五年生存率均无统计学上的显著影响。

相似文献

1
[Surgical treatment of bronchogenic carcinoma. Long-term results in 496 surgical patients].[支气管源性癌的外科治疗。496例手术患者的长期结果]
Cas Lek Cesk. 1998 Apr 6;137(7):211-5.
2
[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].基于分期分类的非小细胞肺癌完全手术切除后的预后
Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. doi: 10.1055/s-2006-956268.
3
Prognosis for resected lung cancer patients with tumors greater than ten centimeters in diameter.直径大于10厘米的肺癌切除患者的预后
Jpn J Clin Oncol. 1990 Dec;20(4):369-73.
4
Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection.伴有胸壁受累的肺癌:手术切除后长期生存的预测因素
Lung Cancer. 2006 Jun;52(3):359-64. doi: 10.1016/j.lungcan.2006.01.010. Epub 2006 Apr 27.
5
The surgical treatment of lung cancer: a retrospective analysis of 2004 cases.肺癌的外科治疗:2004例病例的回顾性分析
Chin Med J (Engl). 1999 Jan;112(1):25-8.
6
Survival after resection of synchronous bilateral lung cancer.同步性双侧肺癌切除术后的生存情况。
Eur J Cardiothorac Surg. 2008 Dec;34(6):1215-22. doi: 10.1016/j.ejcts.2008.07.069. Epub 2008 Oct 1.
7
[Lymphadenectomy in surgery of bronchial carcinoma].[支气管癌手术中的淋巴结清扫术]
Zentralbl Chir. 1996;121(2):87-9.
8
[The surgery of non-small-cell bronchogenic carcinoma in stage IIIA. An analysis of 150 treated cases].[ⅢA期非小细胞支气管肺癌的手术治疗。150例治疗病例分析]
Minerva Chir. 1999 Apr;54(4):219-23.
9
Lung cancer and its operable brain metastasis: survival rate and staging problems.肺癌及其可手术切除的脑转移瘤:生存率与分期问题。
Ann Thorac Surg. 2005 Jan;79(1):241-7; discussion 241-7. doi: 10.1016/j.athoracsur.2004.06.051.
10
An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.术前贫血与接受单纯手术治疗的早期非小细胞肺癌患者生存率降低之间的关联。
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43. doi: 10.1016/j.ijrobp.2004.12.038.